Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Oct 3, 2019
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock
2019-09-30$6.80/sh+76,225$518,330→ 1,277,637 total(indirect: Shares held through RGD Investissements and Lombard International Assurance SA)
Footnotes (1)
- [F1]Effective as of September 30, 2019, an aggregate amount of $518,333 of principal and accrued interest in convertible promissory notes issued to RGD Investissements (the "Notes") converted in accordance with their terms into 76,225 shares of the Issuer's common stock.